NITI Aayog proposes ₹50,000-crore fund and missions for biotech growth by 2035
NITI Aayog has unveiled a roadmap proposing a ₹50,000-crore BioEconomy Growth Fund and six National BioMissions to position India among the top three biotechnology powers by 2035. The strategy aims to expand India's bioeconomy from $195.3 billion in 2025 to $691 billion by 2035, and $2.6 trillion by 2047, while creating over 30 million high-value jobs. The fund will provide blended finance and infrastructure support to bridge the 'valley of death' between research and commercial-scale manufacturing. The BioMissions will focus on areas like gene therapies, climate-resilient crops, synthetic biology, infectious diseases, marine biotechnology, and biologics.
Key Points
- NITI Aayog's roadmap aims to make India a top three biotechnology power by 2035.
- A ₹50,000-crore BioEconomy Growth Fund is proposed to support biomanufacturing and advanced therapeutics.
- The strategy targets expanding India's bioeconomy to $691 billion by 2035 and creating over 30 million high-value jobs.
- Six National BioMissions will focus on specific areas like gene therapies, climate-resilient agriculture, and synthetic biology.
- The initiative emphasizes moving beyond research to building globally competitive biotechnology companies.
Exam Facts
- Body: NITI Aayog.
- Proposed fund: ₹50,000-crore BioEconomy Growth Fund.
- Bioeconomy target: $691 billion by 2035 (from $195.3 billion in 2025).
- Number of National BioMissions: Six.
- Targeted job creation: Over 30 million high-value jobs.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.